Taking heart

May 2003
Engineer (00137758);5/2/2003, Vol. 291 Issue 7626, p9
Features Cardionetics, a remote monitoring technique designed to check the hearts of people taking part in clinical trial of new pharmaceutical products. Use of neural networking technology; Benefits of the device.


Related Articles

  • Cardiac Safety Speaks to the Heart of the Critical Path Initiative. Grisanti, Scott // Applied Clinical Trials;Aug2005, Vol. 14 Issue 8, p53 

    Comments on the significance of the Critical Path Initiative to provide a rational construct for framing the central paradox of new drug and new device development industry. Ability of technology to accelerate development; Identification of the technological advances in discovery; Set of supply...

  • Transparency and Ethics. Kirst, Julie // 24x7;Oct2009, Vol. 14 Issue 10, p8 

    The article reports on the efforts announced by the U.S. Food and Drug Administration (FDA) to better ensure the safety and effectiveness of medical products. It states that the FDA has the authority to disqualify researchers who conduct clinical trials of new devices if they have not followed...

  • Leveraging Clinical Trial Technology: Critical to the Initiative's Success. Cline, John // Applied Clinical Trials;Sep2005, Vol. 14 Issue 9, p56 

    Cites the important role that clinical trial technology will play in the U.S. Food and Drug Administration's Critical Path Initiative for medical products development. Three key dimensions to the "critical path" to product development; Importance of the development of standards in the Critical...

  • FOCUS ON EUROPEAN NEWS.  // Applied Clinical Trials;May2003, Vol. 12 Issue 5, p68 

    Reports on key developments concerning clincial trials for drugs and medical devices in Europe as of May 2003. Key issues of interest; Analysis of pertinent topics; Implications on applied clinical research.

  • Publication Bias in Clinical Trials. Awad, Manal // Journal of the Canadian Dental Association;2010, Vol. 76, p1 

    A blog related to the problem of suppressed information from clinical trials performed on drugs and medical devices is presented.

  • New Device Replaces Damaged Neck Disc.  // Indiana Business Magazine;Oct2003, Vol. 47 Issue 10, p1 

    Reports on the clinical trial for an artificial disc that may be a viable alternative to replace damaged neck disc in the U.S. Replacement of the standard fusion operation by the new therapy; Effectiveness of younger people as candidates for the titanium-polyurethane cervical implant.

  • PREVAIL: Watchman device promising for stroke prevention in nonvalvular AF.  // Cardiology Today;Apr2013, Vol. 16 Issue 4, p1 

    The article discusses the results from the PREVAIL trial on arrhythmia disorders which show that left atrial appendage closure with the Watchman device provides a safe alternative to warfarin in patients with nonvalvular atrial fibrillation.

  • SeptRx begins CE mark trial of the Intrapocket PFO Occluder.  // Medical Device Daily;6/20/2011, Vol. 15 Issue 113, p1 

    The article reports on the launch of the In-tunnel SeptRx European PFO Trial (interSEPT) of the SeptRxIntrapocket PFO Occluder (IPO) developed by SeptRx for the percutaneous transcatheter closure of a heart defect known as patent foramen ovale (PFO), the data from which will be used to apply for...

  • Product Preview.  // Urology Times;9/1/2005, Vol. 33 Issue 11, p43 

    Features several drugs and devices related to urology in the U.S. Submission of a new drug application by Pfizer Inc. for its cancer drug, sunitinib malate (Sutent), as a treatment for metastatic renal cell carcinoma; Initiation of the collaborative second phase clinical trial for the novel...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics